These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 17130347

  • 1. Clopidogrel response variability and future therapies: clopidogrel: does one size fit all?
    O'Donoghue M, Wiviott SD.
    Circulation; 2006 Nov 28; 114(22):e600-6. PubMed ID: 17130347
    [No Abstract] [Full Text] [Related]

  • 2. Aspirin, ticlopidine and clopidogrel in and out of the catheterization laboratory.
    Berger PB.
    J Invasive Cardiol; 1999 Jun 28; 11 Suppl A():20A-29A. PubMed ID: 10745607
    [No Abstract] [Full Text] [Related]

  • 3. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct 28; 18(103):193-5. PubMed ID: 19877380
    [Abstract] [Full Text] [Related]

  • 4. Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.
    Thomas D, Giugliano RP.
    Crit Pathw Cardiol; 2009 Mar 28; 8(1):12-9. PubMed ID: 19258833
    [Abstract] [Full Text] [Related]

  • 5. Clopidogrel in addition to aspirin reduces one-year major adverse cardiac and cerebrovascular events in unselected patients with non-ST segment elevation myocardial infarction.
    Zeymer U, Gitt AK, Zahn R, Jünger C, Bauer T, Köth O, Heer T, Wienbergen H, Gottwik M, Senges J.
    Acute Card Care; 2008 Mar 28; 10(1):43-8. PubMed ID: 17924233
    [Abstract] [Full Text] [Related]

  • 6. Clopidogrel in addition to aspirin reduces in-hospital major cardiac and cerebrovascular events in unselected patients with acute ST segment elevation myocardial.
    Zeymer U, Gitt A, Jünger C, Bauer T, Heer T, Koeth O, Mark B, Zahn R, Senges J, Gottwik M.
    Thromb Haemost; 2008 Jan 28; 99(1):155-60. PubMed ID: 18217148
    [Abstract] [Full Text] [Related]

  • 7. Successful clopidogrel desensitization after drug-eluting stent implantation.
    Kammer RT.
    J Invasive Cardiol; 2009 Mar 28; 21(3):134-5. PubMed ID: 19258645
    [Abstract] [Full Text] [Related]

  • 8. Clopidogrel use in diabetic patients with new stents.
    Cardiovasc J Afr; 2008 Mar 28; 19(4):232. PubMed ID: 18776976
    [No Abstract] [Full Text] [Related]

  • 9. Antiplatelet effect of clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions--limited inhibition of the P2Y12 receptor.
    Lepäntalo A, Virtanen KS, Reséndiz JC, Mikkelsson J, Viiri LE, Karhunen PJ, Lassila R.
    Thromb Res; 2009 Jun 28; 124(2):193-8. PubMed ID: 19232433
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
    Bliden KP, DiChiara J, Tantry US, Bassi AK, Chaganti SK, Gurbel PA.
    J Am Coll Cardiol; 2007 Feb 13; 49(6):657-66. PubMed ID: 17291930
    [Abstract] [Full Text] [Related]

  • 12. Clopidogrel's role in the management of atherosclerotic disease: a focus on acute coronary syndromes.
    Rodgers JE, Steinhubl SR.
    Expert Rev Cardiovasc Ther; 2003 Nov 13; 1(4):507-21. PubMed ID: 15030250
    [Abstract] [Full Text] [Related]

  • 13. Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.
    Hobson A, Curzen N.
    Thromb Haemost; 2009 Jan 13; 101(1):23-30. PubMed ID: 19132185
    [No Abstract] [Full Text] [Related]

  • 14. Clopidogrel: new indication. In combination with aspirin: marginal additional benefits.
    Prescrire Int; 2007 Aug 13; 16(90):146. PubMed ID: 17724837
    [Abstract] [Full Text] [Related]

  • 15. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.
    Gilard M, Arnaud B, Cornily JC, Le Gal G, Lacut K, Le Calvez G, Mansourati J, Mottier D, Abgrall JF, Boschat J.
    J Am Coll Cardiol; 2008 Jan 22; 51(3):256-60. PubMed ID: 18206732
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
    Gibson CM, Murphy SA, Pride YB, Kirtane AJ, Aroesty JM, Stein EB, Ciaglo LN, Southard MC, Sabatine MS, Cannon CP, Braunwald E, TIMI Study Group.
    Am Heart J; 2008 Jan 22; 155(1):133-9. PubMed ID: 18082504
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relation of low response to clopidogrel assessed with point-of-care assay to periprocedural myonecrosis in patients undergoing elective coronary stenting for stable angina pectoris.
    Cuisset T, Hamilos M, Sarma J, Sarno G, Wyffels E, Vanderheyden M, Barbato E, Bartunek J, De Bruyne B, Wijns W.
    Am J Cardiol; 2008 Jun 15; 101(12):1700-3. PubMed ID: 18549843
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.